Gupta Rishi — SEC Form 4 filings
SEC reporting owner CIK 1537370. 7 Form 4 filings on record with FilingPulse; latest filed 2026-02-17.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-02-15 to 2026-02-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 1,033,300 shares, $22,877,262 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 1,000,000 shares @ $22.14 ($22,140,000) in Enliven Therapeutics, Inc., filed 2024-05-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | Director | 5 | — | 2 legs · 1,033,300 sh · $22,877,262 | 5 |
| Turnstone Biologics Corp. (TSBX) | Director | 2 | — | — | 2 |
Form 4 filings — Gupta Rishi
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-17 | 4 | Enliven Therapeutics, Inc. (ELVN) | Grant/award (A): 33,989 (derivative) @ $0 · Grant/award (A): 1,580 (derivative) @ $0 | EDGAR |
| 2025-08-08 | 4 | Turnstone Biologics Corp. (TSBX) | Code (U): 3,099,265 | EDGAR |
| 2025-02-10 | 4 | Enliven Therapeutics, Inc. (ELVN) | Grant/award (A): 20,491 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | Turnstone Biologics Corp. (TSBX) | Grant/award (A): 12,770 (derivative) @ $0 | EDGAR |
| 2024-05-20 | 4 | Enliven Therapeutics, Inc. (ELVN) | Sale (S): 33,300 @ $22.14 · Sale (S): 1,000,000 @ $22.14 | EDGAR |
| 2024-02-20 | 4/A | Enliven Therapeutics, Inc. (ELVN) | Grant/award (A): 23,364 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | Enliven Therapeutics, Inc. (ELVN) | Grant/award (A): 16,835 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1537370 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →